Title : Mutation of Trp29 of human equilibrative nucleoside transporter 1 alters affinity for coronary vasodilator drugs and nucleoside selectivity.

Pub. Date : 2008 Sep 1

PMID : 18462193






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 hENT1 (human equilibrative nucleoside transporter 1) is inhibited by nanomolar concentrations of various structurally distinct coronary vasodilator drugs, including dipyridamole, dilazep, draflazine, soluflazine and NBMPR (nitrobenzylmercaptopurine ribonucleoside). draflazine solute carrier family 29 member 1 (Augustine blood group) Homo sapiens
2 hENT1 (human equilibrative nucleoside transporter 1) is inhibited by nanomolar concentrations of various structurally distinct coronary vasodilator drugs, including dipyridamole, dilazep, draflazine, soluflazine and NBMPR (nitrobenzylmercaptopurine ribonucleoside). draflazine solute carrier family 29 member 1 (Augustine blood group) Homo sapiens
3 Trp29 mutations increased the IC50 values for hENT1 inhibition by dipyridamole, dilazep, NBMPR, soluflazine and draflazine. draflazine solute carrier family 29 member 1 (Augustine blood group) Homo sapiens